ScripAfter years of wondering whether founder and executive chairman Vivek Ramaswamy would take Roivant Sciences public, the multi-subsidiary firm will begin trading on the Nasdaq in the third quarter wh
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biolojic To Use Computational Platform